Target intelligence / Profile preview

Integrin–extracellular matrix interface (Periodontal ligament stem cell)

Molecular classification
Receptor, Extracellular matrix, Other
01

Overview

The integrin–extracellular matrix (ECM) interface between periodontal ligament stem cells (PDLSCs) and the host or preserved ECM is a fundamental biological system governing periodontal tissue repair and regeneration. Integrins, a family of heterodimeric transmembrane receptors, serve as the primary link between the PDLSC cytoskeleton and the surrounding ECM proteins such as collagen, laminin, and fibronectin (Hynes, 2002, Cell). This physical connection facilitates mechanotransduction and activates vital signaling pathways, including the Focal Adhesion Kinase (FAK) and Mitogen-Activated Protein Kinase (MAPK) cascades, which dictate cell fate and osteogenic potential (Chen et al., 2016, J Periodontal Res). In the context of periodontitis or alveolar bone loss, therapeutic strategies often focus on optimizing this interface by using decellularized ECM scaffolds or functionalizing synthetic materials with adhesion motifs like RGD peptides to promote PDLSC recruitment and integration (Seo et al., 2004, Lancet; Zhang et al., 2018, Stem Cells Int). While not a single molecular target, this interface is a focal point for bioengineering efforts aimed at restoring the functional attachment of the tooth to the alveolar bone. Understanding the specific integrin subunits involved, such as alpha-2 and beta-1, is critical for developing targeted regenerative therapies in dentistry.

Other names
PDLSC-ECM interactionIntegrin-mediated adhesion in PDLSCsCell-matrix interface in periodontal ligamentPDLSC-host ECM interface
02

Mechanism of action

Modulation of integrin-mediated signaling pathways (e.g., FAK, ERK, and PI3K/Akt) to enhance cell attachment, survival, and osteogenic differentiation on biological or synthetic scaffolds.

03

Biological functions

Cell adhesionSignal transductionCell differentiationTissue regenerationMechanotransduction
04

Disease associations

InfectionInflammationOther
05

Safety considerations

Risk of unintended systemic cell adhesion interferencePotential for fibrotic responsesScaffold biocompatibility and immunogenicity issuesOff-target effects on non-periodontal tissues
06

Interacting drugs

RGD peptides

3 more in the full profile.

07

Biomarkers

Integrin alpha-2 (ITGA2)Integrin beta-1 (ITGB1)Focal Adhesion Kinase (FAK)VinculinPaxillin

Beyond the preview

Go deeper on Integrin–extracellular matrix interface (Periodontal ligament stem cell).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrin–extracellular matrix interface (Periodontal ligament stem cell).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call